Abdominal obesity may lead to more severe menopause symptoms

Weight gain during menopause is common, with abdominal obesity being especially common and unhealthy. A new study based on data from the Study of Women's Health Across the Nation (SWAN) has found that in addition to its adverse ...

The critical role of exercise in the GLP-1 era

As GLP-1 receptor agonists reshape obesity treatment, a new medical perspective published in JAMA, underscores a persistent gap in care: integrating exercise into weight management in ways patients can sustain.

Gut hormone FGF15 changes how mice respond to weight loss

Nearly 40% of the population in the United States develop obesity, which is linked to the development of several diseases, including type 2 diabetes and metabolic liver disease. The rise in obesity is, in part, caused by ...

page 13 from 40